"/> Novus Biologicals™ Peptide bloquant d’anticorps CC… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps CCDC106

Réf. : BL-RE-081216Réf. fabricant : 18251618 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
29903
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77381. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the carboxy terminus of human CCDC106.

Points forts

Source

Synthetic

(Accession #: NP_037433) The CCDC106 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-081216
Réf. fabricant18251618
Gene ID (Entrez)29903
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77381. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènecoiled-coil domain containing 106, coiled-coil domain-containing protein 106, HSU79303, protein predicted by clone 23882, ZNF581
Symbole de gène(s)CCDC106
Type de produitCCDC106
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the carboxy terminus of human CCDC106
Une question, une configuration particulière ?
Contactez-nous pour un devis.